New York (PRWEB) March 28, 2012
MusclePharm Corp has had an amazing week so far starting at $ 0.145 and going as high as $ 0.30 this morning.
Trading volume is also exploding as there are more than 32 million shares traded only this morning.
MusclePharm Corp most recently released many news that could have propelled the companys shares to these recent highs.
MusclePharm Corp, nutritional supplement company, is pleased to announce that beginning April, 2012, Eurpac Service, Inc. (Eurpac), the primary distributor of consumer products to U.S. military exchanges, U.S. Navy ships and veteran’s canteen services located worldwide will begin distributing the award-winning MusclePharm product line.
This morning MusclePharm Corp. announced it has completed the retirement of all of its outstanding convertible notes held by various financing companies.
Wondering if the current uptrend of MusclePharm Corp shares is going to continue?
Get the Full Report here: http://www.StockReports.net/stocks/MSLP
Pershing Gold Corporation is another stock with a strong week. Starting on Monday at roughly $ 0.50, Shares of Pershing Gold Corporation have traded as high as $ 0.94 today or up almost 100% since Monday.
Pershing Gold Corporation announced that it has signed an agreement with Victoria Gold Corp. to acquire mining claims owned by Victoria’s subsidiary, Victoria Resources (US) Inc., as well as its interests in claims and leaseholds owned by Newmont USA Ltd. that were under lease or sublease.
Pershing Gold Exploration is a new gold exploration and development company focusing on acquiring, exploring, and developing gold deposits in Pershing County and elsewhere in Nevada.
Get the Full Report here: http://www.StockReports.net/stocks/PGLC
Vermillion Inc. a leading molecular diagnostics company, reported financial and operational results for the fourth quarter and full year ended December 31, 2011.
Vermillion Inc. Shares have opened on a strong uptrend yesterday upon news of financial results. Vermillion has seen an increase in revenue and outlined several of the milestones accomplished recently.
This morning shares of Vermillion Inc. were up 18% in premarket trading following news of the company receiving a patent in the United States for its methods for diagnosing ovarian cancer.
Vermillion Inc. has become a frequent pick of StockReports.net having been featured in this watch list several times already in the past.
Get the Full Report here: http://www.StockReports.net/stocks/VRML
News of mergers usually bring their fair share of gainers. However for Amylin Pharmaceuticals it is pretty much the other way around. Amylin Pharmaceuticals is best known for its diabetes drugs Byetta and Bydureon.
Shares of Amylin were up 41% upon news of the company rejecting a hefty takeover bid by none other than Bristol-Myers Squibb. The offer was for $ 3.5 billion.
Executives from both companies declined to comment. It is worth noting however that shares of Amylin Pharmaceuticals have been up 88% in 2012.
Get the Full Report here: http://www.StockReports.net/stocks/AMLN
StockReports.net is a full-service financial communications and investor relations firm that specializes in maximizing investor awareness for micro-cap publicly traded companies.
StockReports.net issues momentum alerts on stocks that can provide gains to day traders.
StockReports.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% – 200% or more.
StockReports.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals StockReports.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the StockReport.net newsletter and receiving alerts from a Pro-Active team of researchers.
Stock Reports believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors you to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: StockReports.net
Disclosure: StockReports.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. StockReports.net is a wholly owned entity of a financial public relations firm. We have not been compensated by any of these companies for this release. Please read our report and visit our website, for complete risks and disclosures.